about
Renin-angiotensin system blockade: Its contribution and controversyDetection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging.Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma.Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy.Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association.Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer.Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.Cancer death from non-muscle invasive bladder cancer: report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.Initial experience of transumbilical laparoendoscopic single-site surgery of partial adrenalectomy in patient with aldosterone-producing adenomaTransumbilical laparo-endoscopic single site surgery for adrenal cortical adenoma inducing primary aldosteronism: initial experienceExpression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin.Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinomaTherapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancerPrognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinomaComparison of continence outcomes of early catheter removal on postoperative day 2 and 4 after laparoscopic radical prostatectomy: a randomized controlled trial.Clinical Background of Patients with Sperm in Their Urinary Sediment.Visceral to total obesity ratio and severe hydronephrosis are independently associated with prolonged pneumoperitoneum operative time in patients undergoing laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma.Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-GuérinEnhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model.Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinomaTherapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancersLymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer.Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression.Obstructive sleep apnea syndrome should be considered as a cause of nocturia in younger patients without other voiding symptoms.The clinical impact of the classification of carcinoma in situ on tumor recurrence and their clinical course in patients with bladder tumor.Extrapancreatic solid pseudopapillary tumor: case report and review of the literature.Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.Metastatic urothelial carcinoma to pericardia manifested by dyspnea from cardiac tamponade during systemic chemotherapy: Case report and literature review.Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy.Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer.Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.Determining When to Stop Prostate Specific Antigen Monitoring after Radical Prostatectomy: the Role of Ultrasensitive Prostate Specific Antigen.Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer.
P50
Q26827221-658F4F3C-533A-489F-9A90-EAFBA92792C4Q30880452-EA1BAD75-D78B-4C7C-A460-046B0AC5A95FQ31098180-DF8721E8-C76E-453D-BA1B-73F86C392E1CQ33382500-70072A5C-3A20-4C34-9825-7459059411F4Q33389349-D0002A99-09CF-41F5-A104-2C8F6E8F0AE0Q33395757-414FF886-4BE8-4E75-AF65-4D921D223374Q33407701-EB4B696E-3717-4956-A015-9EF24B9B5C39Q33726049-F829460E-1EB7-456C-BD3B-7083E14E90E0Q33752074-45F20BA3-92EB-41D1-972B-6C53F1603C34Q34029395-EBAEE155-47DB-4B35-A29E-EC9B5EA55087Q34217487-84C44706-1D52-4F94-B8E0-BE7E6E6AEB4DQ34313378-DED6E631-23D5-4AD6-A993-CC4F67391094Q35588309-98522BBD-29C2-4B5D-81AE-30A7EE9ABB2FQ35618447-3D310A14-5531-4489-88AC-6C05DD138087Q35681985-DFF856FA-9B4C-4E6D-88F8-59EA548D0924Q35727468-45485026-70E1-41FF-86B9-15872E2588CBQ35770400-CB8F4AF3-573C-4B64-B2CA-9064315B0D66Q35772618-801B4918-B53D-448A-ABC1-7A89D07B2778Q35898208-F5250462-32EE-46DE-8DC9-4502647E122FQ36142577-BFEA5B60-9392-4856-9134-C4916EC8CE1EQ36623107-BE906297-5EE3-4166-94CF-B4A21E85DF9DQ36924759-56FD5092-4B66-40C1-9598-3974169E2E94Q37236252-441A728A-9199-4773-ACB7-1A848B300F14Q37252285-6F2AD27F-B2E9-463B-B3DD-4142D0A5F15DQ37331994-FB1B326A-39A8-4513-9C48-7C5662A940BFQ37492636-FE765B91-D022-4AD2-A8B1-2EB611E23879Q37553390-A7B6D73D-9F45-46C1-8F17-82C8F380496BQ37666172-98D28B1E-0042-4997-ACF6-577A7EAC2FC9Q37822211-C62119F6-32DE-4FF0-A233-D5C4D9B3B55FQ37886837-3432ACAB-D5D9-4383-90AA-8ADE4E869381Q37964919-50D8DF0B-4804-4B18-A5EF-36ED8D772FE8Q38055118-03C78F54-154F-4FF7-BB07-9A2C450A2760Q38672188-4F3341EE-922E-456C-AE74-548C197E8E0AQ38691760-4EEC740D-8577-44F1-A4CC-7FF993819D02Q38851961-945129BD-E6D2-4373-ACD5-64C4162FE6D2Q38876399-091355DC-44A3-42B9-B713-6B4CE6CCB5D1Q38927166-F2F2BC42-901B-46C5-ABC8-15E5F228F9D0Q38945229-546789F5-F10E-4550-ACFA-024150DEF060Q38948721-9412C9C8-7AF4-4AB0-9524-DE64AF7E46B5Q38963506-4DCCE20E-A523-40B7-9186-59895056AC85
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eiji Kikuchi
@ast
Eiji Kikuchi
@en
Eiji Kikuchi
@es
Eiji Kikuchi
@nl
Eiji Kikuchi
@sl
type
label
Eiji Kikuchi
@ast
Eiji Kikuchi
@en
Eiji Kikuchi
@es
Eiji Kikuchi
@nl
Eiji Kikuchi
@sl
prefLabel
Eiji Kikuchi
@ast
Eiji Kikuchi
@en
Eiji Kikuchi
@es
Eiji Kikuchi
@nl
Eiji Kikuchi
@sl
P106
P1153
7101880658
P21
P31
P496
0000-0002-1624-6676
P569
2000-01-01T00:00:00Z